Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution

— THERAPEUTIC CATEGORIES —
  • Ocular allergy/inflammation

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Generic Name & Formulations

General Description

Sulfacetamide sodium 100mg, prednisolone sodium phosphate 2.5mg; per mL; contains thimersol.

Pharmacological Class

Antibacterial + steroid.

How Supplied

Contact supplier.

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Indications

Indications

For steroid-responsive inflammatory ocular conditions for which a corticosteroid is indicated and where bacterial infection or a risk of bacterial ocular infection exists.

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Dosage and Administration

Adults and Children

<6yrs: not established. ≥6yrs: instill 2 drops in the eye(s) every 4 hours. Max initial ℞: 20mL.

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Contraindications

Contraindications

Ocular fungal, viral or mycobacterial infections.

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Boxed Warnings

Not Applicable

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Warnings/Precautions

Warnings/Precautions

Do not inject into the eye. Corneal or scleral thinning. Severe dry eye. Glaucoma. Monitor IOP, and for secondary infections in prolonged use. Discontinue if sensitization reaction occurs. Reevaluate if symptoms fail to improve after two days. Pregnancy (Cat.C). Nursing mothers: not recommended.

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Pharmacokinetics

See Literature

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Interactions

Interactions

Incompatible with silver preparations. Local anesthetics related to p-aminobenzoic acid may antagonize the action of sulfonamide.

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Adverse Reactions

Adverse Reactions

Local irritation, sensitization, masks infection, delays healing; in prolonged use: increased IOP, cataracts, corneal perforation, optic nerve damage.

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Clinical Trials

See Literature

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Note

Notes

Formerly known under the brand name Vasocidin.

Sulfacetamide Sodium + Prednisolone Sodium Phosphate Ophthalmic Solution Patient Counseling

See Literature